Login to Your Account



Vermont first state to demand transparency in Rx drug pricing

By Mari Serebrov
Regulatory Editor

Monday, June 6, 2016

State angst over the murky realm of ever-increasing U.S. drug prices has moved from rhetoric to action, with Vermont leading the charge on requiring more transparency from biopharma.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription